Skip to content
2000
image of Psychological Interventions for the Management of Irritable Bowel Syndrome: Understanding the Mind-Gut Connection

Abstract

Objective

This review examines the efficacy of psychological interventions in the management of Irritable Bowel Syndrome (IBS).

Methods

In the current study, a comprehensive analysis of the existing literature, covering case studies and clinical trials, compiled from Google Scholar, Sci-Hub, and PubMed, was performed. The research focused on the complex interplay between psychological factors and irritable bowel syndrome (IBS), particularly the ways in which mental and emotional states can impact IBS symptoms and the effects of behavioral therapy on IBS management.

Results

The efficacy of psychological therapies in addressing irritable bowel syndrome (IBS) has proven effective. Cognitive Behavioral Therapy (CBT) treats pain perception and gastrointestinal symptoms, whereas gut-directed hypnotherapy is known for lowering symptoms and enhancing quality of life. Mindfulness-based stress reduction and relaxation practices are effective for stress management, but their availability is restricted. Personalized treatment strategies tailored to individual requirements are vital for enhancing the advantages of these therapies in IBS management.

Conclusion

Psychological interventions provide a valuable and effective approach to managing IBS. CBT, gut-directed hypnotherapy, and MBSR have been shown to significantly improve symptoms and quality of life. Future research should focus on improving these therapies to better address individual symptoms and brain-gut connections. Incorporating neurological and neurophysiological approaches may improve understanding and lead to more tailored treatments. Expanding accessibility and encouraging collaboration between healthcare providers and mental health specialists will be vital for optimizing IBS management and improving patient outcomes.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cprr/10.2174/0126660822325668241118073750
2025-01-03
2025-07-26

  • From This Site

    /content/journals/cprr/10.2174/0126660822325668241118073750
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Boyce P.M. Koloski N.A. Talley N.J. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am. J. Gastroenterol. 2000 95 11 3176 3183 10.1111/j.1572‑0241.2000.03197.x 11095338
    [Google Scholar]
  2. Hillilä M.T. Färkkilä M.A. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population. Aliment. Pharmacol. Ther. 2004 20 3 339 345 10.1111/j.1365‑2036.2004.02034.x 15274671
    [Google Scholar]
  3. Hungin A.P.S. Whorwell P.J. Tack J. Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment. Pharmacol. Ther. 2003 17 5 643 650 10.1046/j.1365‑2036.2003.01456.x 12641512
    [Google Scholar]
  4. Staudacher H.M. Black C.J. Teasdale S.B. Mikocka-Walus A. Keefer L. Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management. Nat. Rev. Gastroenterol. Hepatol. 2023 20 9 582 596 10.1038/s41575‑023‑00794‑z 37268741
    [Google Scholar]
  5. Hellström P.M. Pathophysiology of the irritable bowel syndrome – Reflections of today. Best Pract. Res. Clin. Gastroenterol. 2019 40-41 101620 10.1016/j.bpg.2019.05.007 31594651
    [Google Scholar]
  6. Camilleri M. Katzka D.A. Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2012 302 10 G1075 G1084 10.1152/ajpgi.00537.2011 22403795
    [Google Scholar]
  7. Camilleri M. Buéno L. Andresen V. De Ponti F. Choi M.G. Lembo A. Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders. Gastroenterology 2016 150 6 1319 1331.e20 10.1053/j.gastro.2016.02.029
    [Google Scholar]
  8. Posserud I. Agerforz P. Ekman R. Björnsson E.S. Abrahamsson H. Simrén M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004 53 8 1102 1108 10.1136/gut.2003.017962 15247175
    [Google Scholar]
  9. Barbara G. Cremon C. Carini G. Bellacosa L. Zecchi L. Giorgio R.D. Corinaldesi R. Stanghellini V. The immune system in irritable bowel syndrome. J. Neurogastroenterol. Motil. 2011 17 4 349 359 10.5056/jnm.2011.17.4.349 22148103
    [Google Scholar]
  10. Kim S.E. Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol. Motil. 2012 24 10 895 913 10.1111/j.1365‑2982.2012.01993.x 22863120
    [Google Scholar]
  11. Mulak A. Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med. Sci. Monit. 2004 10 4 RA55 RA62 15260348
    [Google Scholar]
  12. Konturek S.J. Konturek J.W. Pawlik T. Brzozowski T. Brain-gut axis and its role in the control of food intake. J. Physiol. Pharmacol. 2004 55 1 Pt 2 137 154 15082874
    [Google Scholar]
  13. Mayer E.A. Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu. Rev. Med. 2011 62 1 381 396 10.1146/annurev‑med‑012309‑103958 21090962
    [Google Scholar]
  14. Groot J. Bijlsma P. Kalkeren A.V. Kiliaan A. Saunders P. Perdue M. Stress-induced decrease of the intestinal barrier function. The role of muscarinic receptor activation. Ann. N. Y. Acad. Sci. 2000 915 1 237 246 10.1111/j.1749‑6632.2000.tb05247.x 11193581
    [Google Scholar]
  15. Bonaz B. Sabate J.M. [Brain-gut axis dysfunction]. Gastroenterol. Clin. Biol. 2009 33 Suppl. 1 S48 S58 10.1016/S0399‑8320(09)71525‑8 19303539
    [Google Scholar]
  16. Dorn S.D. Palsson O.S. Thiwan S.I.M. Kanazawa M. Clark W.C. van Tilburg M.A.L. Drossman D.A. Scarlett Y. Levy R.L. Ringel Y. Crowell M.D. Olden K.W. Whitehead W.E. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007 56 9 1202 1209 10.1136/gut.2006.117390 17483191
    [Google Scholar]
  17. Ceuleers H. Van Spaendonk H. Hanning N. Heirbaut J. Lambeir A.M. Joossens J. Augustyns K. De Man J.G. De Meester I. De Winter B.Y. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases. World J. Gastroenterol. 2016 22 47 10275 10286 10.3748/wjg.v22.i47.10275 28058009
    [Google Scholar]
  18. Dekel R. Drossman D.A. Sperber A.D. The use of psychotropic drugs in irritable bowel syndrome. Expert Opin. Investig. Drugs 2013 22 3 329 339 10.1517/13543784.2013.761205 23316916
    [Google Scholar]
  19. Shah K. Ramos-Garcia M. Bhavsar J. Lehrer P. Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis. Behav. Res. Ther. 2020 128 103462 10.1016/j.brat.2019.103462 32229334
    [Google Scholar]
  20. Banerjee A. Sarkhel S. Dhali G.K. Paul I. Das A. A follow-up study of anxiety and depressive symptoms in irritable bowel syndrome. Indian J. Psychiatry 2024 66 2 142 147 10.4103/indianjpsychiatry.indianjpsychiatry_732_23 38523769
    [Google Scholar]
  21. White D.L. Savas L.S. Daci K. Elserag R. Graham D.P. Fitzgerald S.J. Smith S.L. Tan G. El-Serag H.B. Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment. Pharmacol. Ther. 2010 32 4 551 561 10.1111/j.1365‑2036.2010.04387.x 20528828
    [Google Scholar]
  22. Blanchard E.B. Keefer L. Payne A. Turner S.M. Galovski T.E. Early abuse, psychiatric diagnoses and irritable bowel syndrome. Behav. Res. Ther. 2002 40 3 289 298 10.1016/S0005‑7967(01)00057‑2 11863239
    [Google Scholar]
  23. Qin H.Y. Cheng C.W. Tang X.D. Bian Z.X. Impact of psychological stress on irritable bowel syndrome. World J. Gastroenterol. 2014 20 39 14126 14131 10.3748/wjg.v20.i39.14126 25339801
    [Google Scholar]
  24. Singh P. Agnihotri A. Pathak M.K. Shirazi A. Tiwari R.P. Sreenivas V. Sagar R. Makharia G.K. Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J. Neurogastroenterol. Motil. 2012 18 3 324 331 10.5056/jnm.2012.18.3.324 22837881
    [Google Scholar]
  25. Masand P.S. Sousou A.J. Gupta S. Kaplan D.S. Irritable bowel syndrome (IBS) and alcohol abuse or dependence. Am. J. Drug Alcohol Abuse 1998 24 3 513 521 10.3109/00952999809016913 9741950
    [Google Scholar]
  26. Karling P. Danielsson Å. Adolfsson R. Norrback K. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission. Neurogastroenterol. Motil. 2007 19 11 896 904 10.1111/j.1365‑2982.2007.00967.x 17973640
    [Google Scholar]
  27. Sugaya N. Yoshida E. Yasuda S. Tochigi M. Takei K. Ohtani T. Otowa T. Minato T. Umekage T. Sakano Y. Chen J. Shimada H. Nomura S. Okazaki Y. Kaiya H. Tanii H. Sasaki T. Irritable bowel syndrome, its cognition, anxiety sensitivity, and anticipatory anxiety in panic disorder patients. Psychiatry Clin. Neurosci. 2013 67 6 397 404 10.1111/pcn.12069 23890055
    [Google Scholar]
  28. Mayer E.A. Craske M. Naliboff B.D. Depression, anxiety, and the gastrointestinal system. J. Clin. Psychiatry 2001 62 Suppl. 8 28 36 12108819
    [Google Scholar]
  29. Lee S. Wu J. Ma Y.L. Tsang A. Guo W.J. Sung J. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment. Pharmacol. Ther. 2009 30 6 643 651 10.1111/j.1365‑2036.2009.04074.x 19552631
    [Google Scholar]
  30. Gupta S. Masand P.S. Kaplan D. Bhandary A. Hendricks S. The relationship between schizophrenia and irritable bowel syndrome (IBS). Schizophr. Res. 1997 23 3 265 268 10.1016/S0920‑9964(96)00099‑0 9075306
    [Google Scholar]
  31. Garakani A. Win T. Virk S. Gupta S. Kaplan D. Masand P.S. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am. J. Ther. 2003 10 1 61 67 10.1097/00045391‑200301000‑00014 12522523
    [Google Scholar]
  32. Dinan T.G. Quigley E.M.M. Ahmed S.M.M. Scully P. O’Brien S. O’Mahony L. O’Mahony S. Shanahan F. Keeling P.W.N. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006 130 2 304 311 10.1053/j.gastro.2005.11.033 16472586
    [Google Scholar]
  33. Sudo N. Chida Y. Aiba Y. Sonoda J. Oyama N. Yu X.N. Kubo C. Koga Y. Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. J. Physiol. 2004 558 1 263 275 10.1113/jphysiol.2004.063388 15133062
    [Google Scholar]
  34. Rhee S.H. Pothoulakis C. Mayer E.A. Principles and clinical implications of the brain–gut–enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 2009 6 5 306 314 10.1038/nrgastro.2009.35 19404271
    [Google Scholar]
  35. Kiliaan A.J. Saunders P.R. Bijlsma P.B. Berin M.C. Taminiau J.A. Groot J.A. Perdue M.H. Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am. J. Physiol. 1998 275 5 G1037 G1044 9815034
    [Google Scholar]
  36. Demaude J. Salvador-Cartier C. Fioramonti J. Ferrier L. Bueno L. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 2006 55 5 655 661 10.1136/gut.2005.078675 16299034
    [Google Scholar]
  37. Mor N. Haran D. Cognitive-behavioral therapy for depression. Isr. J. Psychiatry Relat. Sci. 2009 46 4 269 273 20635774
    [Google Scholar]
  38. Hunt M.G. Cognitive-Behavioral therapy for irritable bowel syndrome. Using Central Neuromodulators and Psychological Therapies to Manage Patients with Disorders of Gut-Brain Interaction: A Clinical Guide. Springer International Publishing 2019 10.1007/978‑3‑030‑18218‑2_5
    [Google Scholar]
  39. Hauser G. Pletikosic S. Tkalcic M. Cognitive behavioral approach to understanding irritable bowel syndrome. World J. Gastroenterol. 2014 20 22 6744 6758 10.3748/wjg.v20.i22.6744 24944466
    [Google Scholar]
  40. Lackner J.M. Gudleski G.D. Keefer L. Krasner S.S. Powell C. Katz L.A. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 2010 8 5 426 432 10.1016/j.cgh.2010.02.007 20170751
    [Google Scholar]
  41. Lackner J.M. Keefer L. Jaccard J. Firth R. Brenner D. Bratten J. Dunlap L.J. Ma C. Byroads M. IBSOS Research Group The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemp. Clin. Trials 2012 33 6 1293 1310 10.1016/j.cct.2012.07.013 22846389
    [Google Scholar]
  42. Hunt M.G. Moshier S. Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav. Res. Ther. 2009 47 9 797 802 10.1016/j.brat.2009.05.002 19570525
    [Google Scholar]
  43. Moss-Morris R. McAlpine L. Didsbury L.P. Spence M.J. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychol. Med. 2010 40 1 85 94 10.1017/S0033291709990195 19531276
    [Google Scholar]
  44. Van Dulmen A.M. Fennis J.F.M. Bleijenberg G. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. Psychosom. Med. 1996 58 5 508 514 10.1097/00006842‑199609000‑00013 8902902
    [Google Scholar]
  45. Drossman D.A. Toner B.B. Whitehead W.E. Diamant N.E. Dalton C.B. Duncan S. Emmott S. Proffitt V. Akman D. Frusciante K. Le T. Meyer K. Bradshaw B. Mikula K. Morris C.B. Blackman C.J. Hu Y. Jia H. Li J.Z. Koch G.G. Bangdiwala S.I. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157). Gastroenterology 2003 125 1 19 31 10.1016/S0016‑5085(03)00669‑3 12851867
    [Google Scholar]
  46. Jones M. Koloski N. Boyce P. Talley N.J. Pathways connecting cognitive behavioral therapy and change in bowel symptoms of IBS. J. Psychosom. Res. 2011 70 3 278 285 10.1016/j.jpsychores.2010.10.004 21334499
    [Google Scholar]
  47. Everitt H. Landau S. Little P. Bishop F.L. McCrone P. O’Reilly G. Coleman N. Logan R. Chalder T. Moss-Morris R. ACTIB trial team Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults. BMJ Open 2015 5 7 e008622 10.1136/bmjopen‑2015‑008622 26179651
    [Google Scholar]
  48. Surdea-Blaga T. Baban A. Nedelcu L. Dumitrascu D.L. Psychological Interventions for Irritable Bowel Syndrome. J. Gastrointestin. Liver Dis. 2016 25 3 359 366 10.15403/jgld.2014.1121.253.ibs 27689201
    [Google Scholar]
  49. Kassim M.A.K. Pantazi A.C. Nori W. Tuta L.A. Balasa A.L. Mihai C.M. Mihai L. Frecus C.E. Lupu V.V. Lupu A. Andrusca A. Iorga A.M. Litrin R.M. Ion I. Ciciu E. Chirila S.I. Chisnoiu T. Non-pharmacological interventions for pain management in hemodialysis: A narrative review. J. Clin. Med. 2023 12 16 5390 10.3390/jcm12165390 37629432
    [Google Scholar]
  50. Bonnert M. Olén O. Lalouni M. Benninga M.A. Bottai M. Engelbrektsson J. Hedman E. Lenhard F. Melin B. Simrén M. Vigerland S. Serlachius E. Ljótsson B. Internet-delivered cognitive behavior therapy for adolescents with irritable bowel syndrome: a randomized controlled trial. Am. J. Gastroenterol. 2017 112 1 152 162 10.1038/ajg.2016.503 27845338
    [Google Scholar]
  51. Kennedy T. Jones R. Darnley S. Seed P. Wessely S. Chalder T. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005 331 7514 435 10.1136/bmj.38545.505764.06 16093252
    [Google Scholar]
  52. Tkachuk G.A. Graff L.A. Martin G.L. Bernstein C.N. Randomized controlled trial of cognitive–behavioral group therapy for irritable bowel syndrome in a medical setting. J. Clin. Psychol. Med. Settings 2003 10 1 57 69 10.1023/A:1022809914863
    [Google Scholar]
  53. Whorwell P.J. Review article: the history of hypnotherapy and its role in the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2005 22 11-12 1061 1067 10.1111/j.1365‑2036.2005.02697.x 16305719
    [Google Scholar]
  54. Gholamrezaei A. Ardestani S.K. Emami M.H. Where does hypnotherapy stand in the management of irritable bowel syndrome? A systematic review. J. Altern. Complement. Med. 2006 12 6 517 527 10.1089/acm.2006.12.517 16884342
    [Google Scholar]
  55. Harvey R.F. Gunary R.M. Hinton R.A. Barry R.E. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989 333 8635 424 425 10.1016/S0140‑6736(89)90013‑5 2563797
    [Google Scholar]
  56. Chiarioni G. Vantini I. De Iorio F. Benini L. Prokinetic effect of gut‐oriented hypnosis on gastric emptying. Aliment. Pharmacol. Ther. 2006 23 8 1241 1249 10.1111/j.1365‑2036.2006.02881.x 16611286
    [Google Scholar]
  57. Whorwell P.J. Houghton L.A. Taylor E.E. Maxton D.G. Physiological effects of emotion: assessment via hypnosis. Lancet 1992 340 8811 69 72 10.1016/0140‑6736(92)90394‑I 1352012
    [Google Scholar]
  58. Lea R. Houghton L.A. Calvert E.L. Larder S. Gonsalkorale W.M. Whelan V. Randles J. Cooper P. Cruickshanks P. Miller V. Whorwell P.J. Gut‐focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003 17 5 635 642 10.1046/j.1365‑2036.2003.01486.x 12641511
    [Google Scholar]
  59. Gonsalkorale W.M. Toner B.B. Whorwell P.J. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J. Psychosom. Res. 2004 56 3 271 278 10.1016/S0022‑3999(03)00076‑X 15046962
    [Google Scholar]
  60. Gonsalkorale W.M. Houghton L.A. Whorwell P.J. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am. J. Gastroenterol. 2002 97 4 954 961 10.1111/j.1572‑0241.2002.05615.x 12003432
    [Google Scholar]
  61. Rainville P. Duncan G.H. Price D.D. Carrier B. Bushnell M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997 277 5328 968 971 10.1126/science.277.5328.968 9252330
    [Google Scholar]
  62. Lowén M.B.O. Mayer E.A. Sjöberg M. Tillisch K. Naliboff B. Labus J. Lundberg P. Ström M. Engström M. Walter S.A. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2013 37 12 1184 1197 10.1111/apt.12319 23617618
    [Google Scholar]
  63. Nori W. Kassim M.A.K. Helmi Z.R. Pantazi A.C. Brezeanu D. Brezeanu A.M. Penciu R.C. Serbanescu L. Non-pharmacological pain management in labor: a systematic review. J. Clin. Med. 2023 12 23 7203 10.3390/jcm12237203 38068274
    [Google Scholar]
  64. Whorwell P.J. Prior A. Faragher E.B. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984 324 8414 1232 1234 10.1016/S0140‑6736(84)92793‑4 6150275
    [Google Scholar]
  65. Simrén M. Ringström G. Björnsson E.S. Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom. Med. 2004 66 2 233 238 10.1097/01.psy.0000116964.76529.6e 15039508
    [Google Scholar]
  66. Gaylord S.A. Whitehead W.E. Coble R.S. Faurot K.R. Palsson O.S. Garland E.L. Frey W. Mann J.D. Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement. Altern. Med. 2009 9 1 24 10.1186/1472‑6882‑9‑24 19638214
    [Google Scholar]
  67. Zernicke K.A. Campbell T.S. Blustein P.K. Fung T.S. Johnson J.A. Bacon S.L. Carlson L.E. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int. J. Behav. Med. 2013 20 3 385 396 10.1007/s12529‑012‑9241‑6 22618308
    [Google Scholar]
  68. Ghandi F. Sadeghi A. Bakhtyari M. Imani S. Abdi S. Banihashem S.S. Comparing the efficacy of mindfulness-based stress reduction therapy with emotion regulation treatment on quality of life and symptoms of irritable bowel syndrome. Iran. J. Psychiatry 2018 13 3 175 183 30319700
    [Google Scholar]
  69. Gaylord S.A. Palsson O.S. Garland E.L. Faurot K.R. Coble R.S. Mann D.J. Frey W. Leniek K. Whitehead W.E. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am. J. Gastroenterol. 2011 106 9 1678 1688 10.1038/ajg.2011.184 21691341
    [Google Scholar]
  70. Ford A.C. Lacy B.E. Harris L.A. Quigley E.M.M. Moayyedi P. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am. J. Gastroenterol. 2019 114 1 21 39 10.1038/s41395‑018‑0222‑5 30177784
    [Google Scholar]
  71. Svedlund J. Ottosson J-O. Sjödin I. Dotevall G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983 322 8350 589 592 10.1016/S0140‑6736(83)90678‑5 6136745
    [Google Scholar]
  72. Hyphantis T. Guthrie E. Tomenson B. Creed F. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome. Pain 2009 145 1 196 203 10.1016/j.pain.2009.07.005 19643544
    [Google Scholar]
  73. Shirazi M. Ashtiani A. Tabatabaei S.K. Amini M. Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment. Arch. Med. Sci. 2012 1 1 123 129 10.5114/aoms.2012.27292 22457686
    [Google Scholar]
  74. Heymann-Mönnikes I. Arnold R. Florin I. Herda C. Melfsen S. Mönnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am. J. Gastroenterol. 2000 95 4 981 994 10.1016/S0002‑9270(00)00729‑2 10763948
    [Google Scholar]
  75. Kenwright M. McDonald J. Talbot J. Janjua K. Do symptoms of irritable bowel syndrome improve when patients receive cognitive behavioural therapy for co-morbid anxiety disorders in a primary care psychological therapy (IAPT) service? Behav. Cogn. Psychother. 2017 45 5 433 447 10.1017/S1352465817000200 28478779
    [Google Scholar]
  76. Black C.J. Thakur E.R. Houghton L.A. Quigley E.M.M. Moayyedi P. Ford A.C. Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis. Gut 2020 69 8 1441 1451 10.1136/gutjnl‑2020‑321191 32276950
    [Google Scholar]
  77. Hassan W.N.M. Al-kaabi M.M. Akram N.N. Kassim M.A.K. Pantazi A.C. Probiotics for inflammatory bowel disease; A deep dive into their impact on disease course and associated health risks. Curr. Med. Chem. 2024 31 30 4807 4825 10.2174/0109298673314861240429072352 38693730
    [Google Scholar]
/content/journals/cprr/10.2174/0126660822325668241118073750
Loading
Psychological Interventions for the Management of Irritable Bowel Syndrome: Understanding the Mind-Gut Connection
Bentham Science Publishers ; https://doi.org/10.2174/0126660822325668241118073750
/content/journals/cprr/10.2174/0126660822325668241118073750
/content/journals/cprr/10.2174/0126660822325668241118073750
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: cognitive behavioral therapy ; stress ; hypnosis ; Brain-gut axis ; microbiota

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test